Technical Articles
Signaling pathway
How to Choose FGF-R4/CD334: Interaction Data and Acceptance Q&A
A selection guide for recombinant human FGF-R4/CD334: reading interaction data, construct and tag considerations, and arrival acceptance criteria for ligand-binding studies.
View details
- Signaling Pathway
- FGF-R4 selection
- CD334
- interaction data
- acceptance
- binding study
- UA020009
What Is FGF-R4/CD334: Receptor Properties, Ligand Choice and Binding Validation
FGF-R4 (CD334) is an FGF receptor tyrosine kinase whose ligand recognition is shaped by FGF19 and KLB. This article explains receptor characteristics, ligand selection and SPR/ELISA-based binding validation of recombinant human FGF-R4.
View details
- Signaling Pathway
- FGF-R4
- CD334
- FGFR4
- FGF19
- KLB
- receptor
- SPR
- binding assay
- UA020009
How to Choose NRF2: Tag Design and Arrival Acceptance Q&A
A selection guide for recombinant NRF2: construct and tag design considerations, activity readouts and arrival acceptance criteria for oxidative-stress research.
View details
- Signaling Pathway
- NRF2 selection
- NFE2L2
- tag design
- activity
- acceptance
- UA040201
What Is NRF2: The Oxidative-Stress Master Switch and Activity Validation
NRF2 (NFE2L2) is the master transcriptional regulator of the antioxidant response. This article covers the KEAP1-NRF2 axis, ARE-driven gene program and activity validation of recombinant NRF2.
View details
- Signaling Pathway
- NRF2
- NFE2L2
- KEAP1
- ARE
- oxidative stress
- antioxidant response
- activity validation
- UA040201
How to Choose TGF-β1: Activity Judgment and Arrival Acceptance Q&A
A selection guide for TGF-β1: judging activity data, arrival acceptance and supplier considerations for reproducible signaling experiments.
View details
- Signaling Pathway
- TGF-β1 selection
- activity judgment
- arrival acceptance
- supplier
- UA040172
What Is TGF-β1: Latent Activation Mechanism and Activity Determination Guide
TGF-β1 acts through a latent-complex activation mechanism. This article explains latency, activation and Smad signaling, and how to determine activity of recombinant TGF-β1.
View details
- Signaling Pathway
- TGF-β1
- latent activation
- Smad2/3
- activity determination
- recombinant TGF-β1
- UA040172
How to Choose KGF/FGF-7: Activity, Companion Factors and Acceptance Checklist
A selection guide for KGF/FGF-7: reading bioactivity data, pairing with companion factors, and acceptance criteria for reproducible epithelial and organoid cultures.
View details
- Signaling Pathway
- KGF selection
- FGF-7
- bioactivity
- organoid culture
- acceptance criteria
- UA040110
What Is KGF/FGF-7: Epithelial-Specific Growth Factor Mechanism and Organoid Use
KGF (FGF-7) is an epithelial-specific FGF family member acting through FGFR2b. This article explains its mechanism, epithelial proliferation roles and organoid-culture applications.
View details
- Signaling Pathway
- KGF
- FGF-7
- keratinocyte growth factor
- FGFR2b
- epithelial cell
- organoid
- tissue repair
- UA040110
TGF-β1 in Translation: Fibrosis, Tumor Microenvironment and Drug Strategies
TGF-β1 sits at the center of fibrosis and immunosuppressive tumor microenvironment research. This article reviews ALK5 inhibitors, ligand traps and translational study design around TGF-β1.
View details
- Signaling Pathway
- TGF-β1 target
- ALK5 inhibitor
- ligand trap
- tumor microenvironment
- fibrosis
- immunosuppression
- UA040172
Working with TGF-β1: Stabilizing Cell-Treatment Activity Readouts
A practical guide to TGF-β1 cell treatment: low-concentration adsorption and carrier protein, phosphorylated Smad2/3 readouts, reporter assays and troubleshooting variable activity data.
View details
- Signaling Pathway
- TGF-β1 cell treatment
- adsorption
- carrier protein
- phospho-Smad2/3
- reporter assay
- troubleshooting
- UA040172
- 1
- 2
- 3
- 4
- 5
- 6
- 18
















